We are live on ! Find out more
BCP

Balance Capital Partners Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
+41.79%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$51.4M
Cap. Flow
+$17.6M
Cap. Flow %
12.61%
Top 10 Hldgs %
100%
Holding
13
New
7
Increased
1
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$8.65M
2
TSM icon
TSMC
TSM
+$4.46M
3
CPNG icon
Coupang
CPNG
+$3.55M
4
SN icon
SharkNinja
SN
+$2.46M
5
TTMI icon
TTM Technologies
TTMI
+$2.1M

Top Sells

Rank Stock Value
1
STVN icon
Stevanato
STVN
+$4.54M
2
GEV icon
GE Vernova
GEV
+$2.36M
3
CLBT icon
Cellebrite
CLBT
+$1.45M

Sector Composition

Rank Sector Weight
1 Materials 70%
2 Technology 7.44%
3 Miscellaneous 7.27%
4 Industrials 6.69%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRM icon
1
Perimeter Solutions
PRM
$5.2B
$97.5M 70%
2,735,521
– –
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$10.1M 7.27%
+64,000
New +$8.65M
RHLD
3
Resolute Holdings Management
RHLD
$1.07B
$9.33M 6.69%
64,526
– –
TSM icon
4
TSMC
TSM
$2.22T
$5.25M 3.77%
+11,000
New +$4.46M
BLTE
5
Belite Bio
BLTE
$7.8B
$3.46M 2.49%
22,500
+8,000
+55% +$1.23M
CPNG icon
6
Coupang
CPNG
$27.5B
$3.42M 2.45%
+196,897
New +$3.55M
SN icon
7
SharkNinja
SN
$24.4B
$3.12M 2.24%
+20,504
New +$2.46M
MRVL icon
8
Marvell Technology
MRVL
$201B
$2.68M 1.92%
+9,000
New +$1.8M
TTMI icon
9
TTM Technologies
TTMI
$13.2B
$2.43M 1.75%
+13,000
New +$2.1M
DNA icon
10
Ginkgo Bioworks
DNA
$468M
$1.97M 1.42%
+199,009
New +$1.66M
CLBT icon
11
Cellebrite
CLBT
$2.88B
– –
-105,279
Closed -$1.45M
STVN icon
12
Stevanato
STVN
$5.6B
– –
-330,534
Closed -$4.54M
GEV icon
13
GE Vernova
GEV
$251B
– –
-2,700
Closed -$2.36M

Similar funds

AFC
Ares Financial Consulting Calabasas, California $139M AUM
CPC
Cadia Private Client Parsippany, New Jersey $139M AUM
HFA
Hershey Financial Advisers Lancaster, Pennsylvania $139M AUM 70.34% 1-Year Est. Return
HWM
HBE Wealth Management Lincoln, Nebraska $139M AUM
BAM
Brickwood Asset Management London, United Kingdom $139M AUM 3.28% 1-Year Est. Return
PU
Petiole USA New York $139M AUM 34.86% 1-Year Est. Return
BIO
Blue Investment Opportunities Miami Beach, Florida $140M AUM 19.78% 1-Year Est. Return
PAM
PCG Asset Management Gladstone, New Jersey $140M AUM 23.79% 1-Year Est. Return

Balance Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Balance Capital Partners held 13 positions worth $139M, up 58% from $87.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Balance Capital Partners deployed $17.6M of net new capital in Q2 2026, opening 7 new positions and adding to 1 existing holding. Its largest new stake was State Street SPDR S&P Biotech ETF: 64,000 shares worth $10.1M.

By sector, the portfolio is most concentrated in Materials at 70% of assets, down from 76% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the most notable exit was Stevanato, an estimated $4.54M sold.

  • Balance Capital Partners's largest Q2 2026 buy was State Street SPDR S&P Biotech ETF: 64,000 shares worth $10.1M.
  • Balance Capital Partners added most to Belite Bio in Q2 2026, an estimated $1.23M increase.
  • Balance Capital Partners fully exited Stevanato in Q2 2026, selling an estimated $4.54M.
  • Balance Capital Partners's ten largest holdings make up 100% of its $139M portfolio in Q2 2026.
  • Balance Capital Partners opened 7 new positions and closed 3 in Q2 2026.
  • Balance Capital Partners's portfolio value rose 58% quarter-over-quarter to $139M.

Based on Balance Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.